Insider · CIK 0001291963

Greene Barry E

Reports to the SEC for 8 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001291963

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-15	CTYCITY THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+22.6K sh	—	—	22,649
2026-06-22	DYNDyne Therapeutics, Inc. · Stock option (right to buy)A Award	Director	AAward	+57.5K sh	—	—	57,463
2026-05-21	KPTIKaryopharm Therapeutics Inc.A Award	Director	AAward	+15.5K sh	—	—	16,415
2025-07-31	Sage Therapeutics, Inc.U Disposition from Tender	Director, President and CEO	UDisposition from Tender	−46.9K sh	—	—	0
2025-07-31	Sage Therapeutics, Inc.D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−53.2K sh	—	—	0
2025-07-31	Sage Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−174K sh	—	—	0
2025-05-28	KPTIKaryopharm Therapeutics Inc. · Nonstatutory Stock Option (right to buy)A Award	Director	AAward	+4,600 sh	—	—	4,600
2025-04-10	Sage Therapeutics, Inc.A Award	Director, President and CEO	AAward	+20K sh	—	—	105,031
2025-04-10	Sage Therapeutics, Inc.F Tax Payment	Director, President and CEO	FTax Payment	−4,862 sh	$6.91	−$33.6K	100,169
2025-01-16	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+174K sh	—	—	174,000
2024-08-05	Sage Therapeutics, Inc.A Award	Director, President and CEO	AAward	+50.4K sh	—	—	97,340
2024-08-05	Sage Therapeutics, Inc.F Tax Payment	Director, President and CEO	FTax Payment	−12.3K sh	$8.96	−$110K	85,067
2024-05-29	KPTIKaryopharm Therapeutics Inc. · Nonstatutory Stock Option (right to buy)A Award	Director	AAward	+69K sh	—	—	69,000
2024-02-13	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+168K sh	—	—	168,000
2023-08-04	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+195K sh	—	—	195,000
2023-05-24	KPTIKaryopharm Therapeutics Inc. · Nonstatutory Stock Option (right to buy)A Award	Director	AAward	+34K sh	—	—	34,000
2023-02-13	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+66.5K sh	—	—	66,500
2022-11-10	Sage Therapeutics, Inc.P Purchase	Director, President and CEO	PPurchase	+14.5K sh	$34.48	+$500K	46,940
2022-08-11	KPTIKaryopharm Therapeutics Inc.M Exercise/Conversion	Director	MExercise/Conversion	+7,576 sh	$1.49	+$11.3K	13,606
2022-08-11	KPTIKaryopharm Therapeutics Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−7,576 sh	—	—	0
2022-05-19	KPTIKaryopharm Therapeutics Inc. · Nonstatutory Stock Option (right to buy)A Award	Director	AAward	+23.9K sh	—	—	23,900
2022-02-11	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+69.9K sh	—	—	69,920
2021-08-05	Sage Therapeutics, Inc.P Purchase	Director, President and CEO	PPurchase	+23.6K sh	$43.15	+$1.02M	32,440
2021-06-16	Sage Therapeutics, Inc.P Purchase	Director, President and CEO	PPurchase	+8,800 sh	$56.32	+$496K	8,800
2021-06-02	Acorda Therapeutics, Inc.Non-Employee Stock OptionA Award	Director	AAward	+10K sh	—	—	10,000
2021-05-21	KPTIKaryopharm Therapeutics Inc. · Nonstatutory Stock Option (right to buy)A Award	Director	AAward	+23.9K sh	—	—	23,900
2021-01-04	Sage Therapeutics, Inc.Stock Options (Right to buy)A Award	Director, President and CEO	AAward	+390K sh	—	—	390,000
2020-10-01	Sage Therapeutics, Inc.Stock Options (Right to buy)A Award	Director, President and CEO	AAward	+20K sh	—	—	20,000
2020-09-09	ALNYALNYLAM PHARMACEUTICALS, INC.M Exercise/Conversion	President	MExercise/Conversion	+44.5K sh	$9.14	+$407K	114,873
2020-09-09	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	President	SSale	−14.1K sh	$122.66	−$1.73M	100,798
2020-09-09	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	President	SSale	−27.1K sh	$123.39	−$3.34M	73,689
2020-09-09	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	President	SSale	−3,346 sh	$124.38	−$416K	70,343
2020-09-09	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	President	MExercise/Conversion	−44.5K sh	—	—	0
2020-08-10	ALNYALNYLAM PHARMACEUTICALS, INC.M Exercise/Conversion	President	MExercise/Conversion	+1,587 sh	$63.00	+$100K	63,823
2020-08-10	ALNYALNYLAM PHARMACEUTICALS, INC.M Exercise/Conversion	President	MExercise/Conversion	+1,036 sh	$96.45	+$99.9K	64,859
2020-08-10	ALNYALNYLAM PHARMACEUTICALS, INC.M Exercise/Conversion	President	MExercise/Conversion	+1,124 sh	$88.95	+$100K	65,983
2020-08-10	ALNYALNYLAM PHARMACEUTICALS, INC.M Exercise/Conversion	President	MExercise/Conversion	+1,184 sh	$42.22	+$50K	67,167
2020-08-10	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	President	MExercise/Conversion	−1,184 sh	—	—	23,816
2020-08-10	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	President	MExercise/Conversion	−1,587 sh	—	—	88,413
2020-08-10	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	President	MExercise/Conversion	−1,124 sh	—	—	38,876
2020-08-10	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	President	MExercise/Conversion	−1,036 sh	—	—	46,589
2020-07-16	ALNYALNYLAM PHARMACEUTICALS, INC.G Gift	President	GGift	+3,176 sh	—	—	65,412
2020-07-16	ALNYALNYLAM PHARMACEUTICALS, INC.G Gift	President	GGift	+155 sh	—	—	155
2020-07-16	ALNYALNYLAM PHARMACEUTICALS, INC.G Gift	President	GGift	−155 sh	—	—	3,331
2020-07-16	ALNYALNYLAM PHARMACEUTICALS, INC.G Gift	President	GGift	−155 sh	—	—	3,176
2020-07-16	ALNYALNYLAM PHARMACEUTICALS, INC.G Gift	President	GGift	−3,176 sh	—	—	0
2020-07-07	ALNYALNYLAM PHARMACEUTICALS, INC.M Exercise/Conversion	President	MExercise/Conversion	+22.3K sh	$9.14	+$204K	84,501
2020-07-07	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	President	SSale	−22.3K sh	$159.99	−$3.56M	62,236
2020-07-07	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	President	MExercise/Conversion	−22.3K sh	—	—	44,530
2020-06-15	Acorda Therapeutics, Inc.Non-Employee Stock OptionA Award	Director	AAward	+15K sh	—	—	15,000

Recent filings

Accepted (ET)
Oct 194
Greene Barry E0001104659-26-116956
SEC(opens sec.gov)
Jun 234
Greene Barry E0001291963-26-000008
SEC(opens sec.gov)
May 264
Greene Barry E0001291963-26-000004
SEC(opens sec.gov)
Jul 314
Greene Barry E0000950170-25-100636
SEC(opens sec.gov)
May 294
Greene Barry E0000950170-25-078944
SEC(opens sec.gov)
Apr 114
Greene Barry E0001562180-25-003112
SEC(opens sec.gov)
Jan 214
Greene Barry E0001562180-25-000437
SEC(opens sec.gov)
Aug 74
Greene Barry E0001562180-24-006090
SEC(opens sec.gov)
May 304
Greene Barry E0000950170-24-066781
SEC(opens sec.gov)
Feb 154
Greene Barry E0001562180-24-001336
SEC(opens sec.gov)
Aug 84
Greene Barry E0001562180-23-006237
SEC(opens sec.gov)
May 254
Greene Barry E0001209191-23-032137
SEC(opens sec.gov)
Feb 154
Greene Barry E0001562180-23-001422
SEC(opens sec.gov)
Nov 154
Greene Barry E0001562180-22-007667
SEC(opens sec.gov)
Aug 154
Greene Barry E0001209191-22-045718
SEC(opens sec.gov)

Companies

Address

399 BINNEY STREET

CAMBRIDGE, MA, 02142